Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia

Objective This study aimed to provide evidence to improve cervical screening for women living with HIV (WLHIV). We assessed the accuracy of screening tests that can be used in low-resource settings and give results at the same visit.Methods and analysis We conducted a paired, prospective study among...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicola Low, Partha Basu, Andreas Limacher, Katayoun Taghavi, Misinzo Moono, Mulindi Mwanahamuntu, Herbert Kapesa, Albert Manasyan, Julia Bohlius, Marie Roumet, Thamsanqa Madliwa, Anne Rutjes
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/3/1/e000111.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582046889803776
author Nicola Low
Partha Basu
Andreas Limacher
Katayoun Taghavi
Misinzo Moono
Mulindi Mwanahamuntu
Herbert Kapesa
Albert Manasyan
Julia Bohlius
Marie Roumet
Thamsanqa Madliwa
Anne Rutjes
author_facet Nicola Low
Partha Basu
Andreas Limacher
Katayoun Taghavi
Misinzo Moono
Mulindi Mwanahamuntu
Herbert Kapesa
Albert Manasyan
Julia Bohlius
Marie Roumet
Thamsanqa Madliwa
Anne Rutjes
author_sort Nicola Low
collection DOAJ
description Objective This study aimed to provide evidence to improve cervical screening for women living with HIV (WLHIV). We assessed the accuracy of screening tests that can be used in low-resource settings and give results at the same visit.Methods and analysis We conducted a paired, prospective study among consecutive eligible WLHIV, aged 18–65 years, receiving cervical cancer screening at one hospital in Lusaka, Zambia. The histopathological reference standard was multiple biopsies taken at two time points. The target condition was cervical intraepithelial neoplasia grade 2 and above (CIN2+). The index tests were high-risk human papillomavirus detection (hrHPV, Xpert HPV, Cepheid), portable colposcopy (Gynocular, Gynius) and visual inspection with acetic acid (VIA). Accuracy of stand-alone and test combinations were calculated as the point estimate with 95% CIs. A sensitivity analysis considered disease when only visible lesions were biopsied.Results Women included in the study had well-controlled HIV infection (median CD4 count=542 cells/mm3) and all except one were on antiretroviral therapy. Among 371 participants with histopathological results, 27% (101/371) women had CIN2+ and 23% (23/101) were not detected by any index test. Sensitivity and specificity for stand-alone tests were: hrHPV, 67.3% (95% CI 57.7% to 75.7%) and 65.3% (95% CI 59.4% to 70.7%); Gynocular 51.5% (95% CI 41.9% to 61.0%) and 80.0% (95% CI 74.8% to 84.3%); and VIA 22.8% (95% CI 15.7% to 31.9%) and 92.6% (95% CI 88.8% to 95.2%), respectively. Combining tests did not improve test accuracy measures. All test accuracies improved in sensitivity analysis.Conclusion The low accuracy of screening tests assessed might be explained by our reference standard, which reduced verification and misclassification biases. Better screening strategies for WLHIV in low-resource settings are urgently needed.Trial registration number NCT03931083.
format Article
id doaj-art-afc32ecab0054dfaa7b2313cefec710a
institution Kabale University
issn 2752-7948
language English
publishDate 2024-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Oncology
spelling doaj-art-afc32ecab0054dfaa7b2313cefec710a2025-01-30T06:15:12ZengBMJ Publishing GroupBMJ Oncology2752-79482024-07-013110.1136/bmjonc-2023-000111Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, ZambiaNicola Low0Partha Basu1Andreas Limacher2Katayoun Taghavi3Misinzo Moono4Mulindi Mwanahamuntu5Herbert Kapesa6Albert Manasyan7Julia Bohlius8Marie Roumet9Thamsanqa Madliwa10Anne Rutjes11Institute of Social and Preventative Medicine, University of Bern, Bern, SwitzerlandInternational Agency for Research on Cancer, Lyon, FranceDepartment of Clinical Research, University of Bern, Bern, SwitzerlandInstitute of Social and Preventative Medicine, University of Bern, Bern, SwitzerlandCenter for Infectious Disease Research in Zambia, Lusaka, ZambiaUniversity of Zambia University Teaching Hospital, Lusaka, ZambiaCenter for Infectious Disease Research in Zambia, Lusaka, ZambiaCenter for Infectious Disease Research in Zambia, Lusaka, ZambiaInstitute of Social and Preventative Medicine, University of Bern, Bern, SwitzerlandDepartment of Clinical Research, University of Bern, Bern, SwitzerlandDepartment of histopathology, Lancet Laboratories, Richmond, South AfricaInstitute of Social and Preventative Medicine, University of Bern, Bern, SwitzerlandObjective This study aimed to provide evidence to improve cervical screening for women living with HIV (WLHIV). We assessed the accuracy of screening tests that can be used in low-resource settings and give results at the same visit.Methods and analysis We conducted a paired, prospective study among consecutive eligible WLHIV, aged 18–65 years, receiving cervical cancer screening at one hospital in Lusaka, Zambia. The histopathological reference standard was multiple biopsies taken at two time points. The target condition was cervical intraepithelial neoplasia grade 2 and above (CIN2+). The index tests were high-risk human papillomavirus detection (hrHPV, Xpert HPV, Cepheid), portable colposcopy (Gynocular, Gynius) and visual inspection with acetic acid (VIA). Accuracy of stand-alone and test combinations were calculated as the point estimate with 95% CIs. A sensitivity analysis considered disease when only visible lesions were biopsied.Results Women included in the study had well-controlled HIV infection (median CD4 count=542 cells/mm3) and all except one were on antiretroviral therapy. Among 371 participants with histopathological results, 27% (101/371) women had CIN2+ and 23% (23/101) were not detected by any index test. Sensitivity and specificity for stand-alone tests were: hrHPV, 67.3% (95% CI 57.7% to 75.7%) and 65.3% (95% CI 59.4% to 70.7%); Gynocular 51.5% (95% CI 41.9% to 61.0%) and 80.0% (95% CI 74.8% to 84.3%); and VIA 22.8% (95% CI 15.7% to 31.9%) and 92.6% (95% CI 88.8% to 95.2%), respectively. Combining tests did not improve test accuracy measures. All test accuracies improved in sensitivity analysis.Conclusion The low accuracy of screening tests assessed might be explained by our reference standard, which reduced verification and misclassification biases. Better screening strategies for WLHIV in low-resource settings are urgently needed.Trial registration number NCT03931083.https://bmjoncology.bmj.com/content/3/1/e000111.full
spellingShingle Nicola Low
Partha Basu
Andreas Limacher
Katayoun Taghavi
Misinzo Moono
Mulindi Mwanahamuntu
Herbert Kapesa
Albert Manasyan
Julia Bohlius
Marie Roumet
Thamsanqa Madliwa
Anne Rutjes
Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia
BMJ Oncology
title Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia
title_full Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia
title_fullStr Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia
title_full_unstemmed Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia
title_short Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia
title_sort accuracy of screening tests for cervical precancer in women living with hiv in low resource settings a paired prospective study in lusaka zambia
url https://bmjoncology.bmj.com/content/3/1/e000111.full
work_keys_str_mv AT nicolalow accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT parthabasu accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT andreaslimacher accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT katayountaghavi accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT misinzomoono accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT mulindimwanahamuntu accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT herbertkapesa accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT albertmanasyan accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT juliabohlius accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT marieroumet accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT thamsanqamadliwa accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia
AT annerutjes accuracyofscreeningtestsforcervicalprecancerinwomenlivingwithhivinlowresourcesettingsapairedprospectivestudyinlusakazambia